Central Venous Catheter Market By Product type (Tunneled Catheters, Non-Tunneled Catheters), By Property (Antimicrobial Catheters, Non-Antimicrobial Catheters), By Design (Single Lumen, Double Lumen, Multiple Lumen), By End-User (Hospital, Cancer treatmen

Central Venous Catheter Market By Product type (Tunneled Catheters, Non-Tunneled Catheters), By Property (Antimicrobial Catheters, Non-Antimicrobial Catheters), By Design (Single Lumen, Double Lumen, Multiple Lumen), By End-User (Hospital, Cancer treatment centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

The central venous catheter market was valued at $2,571.23 million in 2022 and is estimated to reach $4,730.10 million by 2032, exhibiting a CAGR of 6.4% from 2023 to 2032.

Central venous catheters are defined as an indwelling device inserted into a large, central vein such as internal jugular, subclavian, or femoral. Central venous catheters are used for blood transfusion and infusion of chemotherapy drugs. These catheters are available with various numbers of lumens.

The growth of the central venous catheter market is driven by surge in incidence of cardiovascular diseases, increase in availability & affordability of healthcare treatment and rise in number of hospital admission. The increase in incidence of acute kidney injury and kidney failure drives the demand for central venous catheters. These catheters are used for hemodialysis. For instance, according to American Kidney Fund, in 2020, more than 562,000 Americans were on dialysis. Growth in a number of hemodialysis thus consequently drives the market growth.

Moreover, large medical technology firms have increasingly focused on acquiring companies that provide solutions for central venous catheters, which is expected to notably contribute toward the market growth. Prominent players in the global central venous catheter market have adopted various strategies such as product launches, acquisitions, and investments in R&D for advancement in central venous catheters to strengthen their position in the market and sustain the competitive environment. For instance, in January 2021, Shenzhen Prunus Technology Co., Ltd., acquired the critical care products division of Biosensors International Group, Ltd, officially entering the field of critical care consumables business. The acquired products of the subsidiary include central venous catheters, pressure transducers, pulmonary artery catheters, pacing catheters, thrombolysis catheters, urinary catheters, and other medical consumables.

Moreover, alarming increase in prevalence of kidney diseases, technological advancements in central venous catheter, and rise in the number of accidents and trauma are some of the key factors that drive the growth of the market. Furthermore, rise in geriatric population and changes in lifestyles notably contribute toward the growth in prevalence of diseases. However, concern related to catheter infections and product recalls by manufacturers is expected to hamper the market growth. Conversely, increased application of central venous catheter among the geriatric population and emergency health conditions is expected to provide lucrative opportunities for the growth of the market in the near future. In addition, extensive R&D activities in the field of central venous catheter along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market during the forecast period.

The central venous catheter market is segmented into product type, property, design, end user, and region. On the basis of product type, the market is bifurcated into tunneled catheters and non-tunneled catheters. On the basis of property, the market is bifurcated into antimicrobial catheters and non-antimicrobial catheters. On the basis of design, the market is classified into single lumen, double lumen and multiple lumens. On the basis of end user, it is classified into hospitals, cancer treatment centers, and others. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major companies profiled in the report include AngioDynamics, Asahi Kasei Corporation., B. Braun, Becton Dickinson and Company, ICU Medical, Medtronic plc., Merit medical, Rex Medical, Teleflex Incorporated and Vygon Ltd.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the central venous catheter market analysis from 2022 to 2032 to identify the prevailing central venous catheter market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the central venous catheter market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global central venous catheter market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product type

Tunneled Catheters
Non-Tunneled Catheters

By Property

Antimicrobial Catheters
Non-Antimicrobial Catheters

By Design

Single Lumen
Double Lumen
Multiple Lumen

By End-User

Hospital
Cancer treatment centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
B. Braun SE
ICU Medical Inc.
AngioDynamics, Inc.
Medtronic plc
Rex Medical, LLC.
Vygon
Asahi Kasei Corporation.
Becton, Dickinson and Company
Merit Medical Systems Inc.
Teleflex Incorporated

Please Note: It will take 7-10 business days to complete the report upon order confirmation.